Changes in plasma natriuretic peptide levels in patients with atrial fibrillation after cardioversion

International Journal of Cardiology

Volumn 144, Issue 3, 2010, Pages 436-437

  Wozakowska Kaplon, Beata ^a,b  

^a JAN KOCHANOWSKI UNIVERSITY   (Poland)

^b Dept of Cardiology Regional District Hospital ^*  (Poland)

Author keywords

Atrial fibrillation; Cardioversion; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

BLOOD SAMPLING; CARDIOVERSION; CLINICAL TRIAL; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 77957862283     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.03.085     Document Type: Article

References (3)

1. M.A. Silver, A. Maisel, and C.W. Yancy BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases Congest Heart Fail 10 suppl.3 2004 1 30
2. E.R. Levin, D.G. Gardner, and W.K. Samson Natriuretic peptides N Engl J Med 339 1998 321 328
3. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150